Cases of congenital dyserythropoietic anemia (CDA) that do not conform to any of the three classical types often present diagnostic difficulties and are at risk of developing secondary hemochromatosis. Here, we report a case of a six year old boy with transfusion dependency and gross abnormalities of the erythroblasts. Haematologica 2007; 92:1427 92: -1428 Case 484/01 of the German Registry of Congenital Dyserythropoietic anemias, male, is the only child of healthy, non-consanguineous German parents. Birth weight was 3,750 g, and there are no dysmorphologies. Scleral icterus and pallor was first noticed at the age of two months. Lowest hemoglobin concentration was 5.4 g/dL, with an MCV of 89 fL and a reticulocyte count of 1.4%. No splenomegaly was noted at the most recent examination at the age of six years. Regular red cell transfusions were given at monthly intervals which ensured a target hemoglobin concentration between 7-12 g /dL. Serum ferritin reached 1,850 ng/mL at the age of 3 years. Non-invasive estimation by superconducting quantum interference device biomagnetometry (SQUID) showed a greatly increased liver iron.
(SDS-PAGE) was normal. Sequencing of the CDANIgene 1 failed to show mutations. Hb A2 and HbF were not increased. Iron studies consistently showed data compatible with secondary hemochromatosis which was not sufficiently controlled by deferoxamine therapy. At the age of six, serum ferritin was still increased at 930 ng/mL, transferrin was decreased at 1.3 g/L, transferrin saturation was 100% and the soluble transferrin receptor 4.6 mg/L (reference 0.8-1.8 mg/L). Creatinine, ALT, AST and serum concentrations of albumin, cortisol, TSH and glucose were all within normal limits.
The case described fulfills the general definition criteria of the CDAs, 2 but cannot be attributed to CDA I, II or III, or to any of the other entities described as CDA variants or groups.
3 Its congenital nature is shown by anemia and 
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jaundice in infancy and consistency of the abnormal laboratory data during the observation period of six years. Erythropoiesis is ineffective, as shown by severe anemia requiring regular red cell transfusions with low reticulocyte counts, erythropoietic hyperplasia, and increased serum concentration of the soluble transferrin receptor. The disorder is the result of autosomal inheritance or due to de novo mutations, since both parents and their siblings had normal blood counts. Analysis of cases of CDA reported as variants did not reveal a similar case, with the exception of a patient described from Spain, 4 who was reported to present similarly extensive morphological aberrations. In contrast to out report, the anemia was less severe and transfusions were only required in the first three months.
In the case reported here, transfusions still had to be given at the age of six. This resulted in iron overload which standard therapy with deferoxamine could not adequately control. Since there is no intervention available to correct the unknown genetic defect leading to ineffective erythropoiesis, matched unrelated hemopoietic stem cell transplantation is under consideration. 
